These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 2198471)

  • 1. Empty MHC class I molecules come out in the cold.
    Ljunggren HG; Stam NJ; Ohlén C; Neefjes JJ; Höglund P; Heemels MT; Bastin J; Schumacher TN; Townsend A; Kärre K
    Nature; 1990 Aug; 346(6283):476-80. PubMed ID: 2198471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines.
    Anderson KS; Alexander J; Wei M; Cresswell P
    J Immunol; 1993 Oct; 151(7):3407-19. PubMed ID: 8376783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
    De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
    Sibille C; Gould K; Hämmerling G; Townsend A
    Eur J Immunol; 1992 Feb; 22(2):433-40. PubMed ID: 1537379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of H-2b expression and processing of endogenous antigens in the MHC class I pathway by fusion of a lymphoma mutant to L cells of the H-2k haplotype.
    Ohlén C; Bastin J; Ljunggren HG; Imreh S; Klein G; Townsend AR; Kärre K
    Eur J Immunol; 1990 Aug; 20(8):1873-6. PubMed ID: 2120065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure in expression of structurally altered (CYS164-->TYR) H-2Kb molecules is mitigated with high affinity peptide-ligand.
    Tatake RJ; Zeff RA
    Transplantation; 1995 May; 59(9):1343-9. PubMed ID: 7762072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules.
    Germain RN; Rinker AG
    Nature; 1993 Jun; 363(6431):725-8. PubMed ID: 8515815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression.
    Otten GR; Bikoff E; Ribaudo RK; Kozlowski S; Margulies DH; Germain RN
    J Immunol; 1992 Jun; 148(12):3723-32. PubMed ID: 1602127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide ligand-induced conformation and surface expression of the Ld class I MHC molecule.
    Lie WR; Myers NB; Gorka J; Rubocki RJ; Connolly JM; Hansen TH
    Nature; 1990 Mar; 344(6265):439-41. PubMed ID: 2157157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate of the three subunits of major histocompatibility complex class I molecules.
    Neefjes JJ; Smit L; Gehrmann M; Ploegh HL
    Eur J Immunol; 1992 Jun; 22(6):1609-14. PubMed ID: 1318200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides.
    Jefferies WA; Kolaitis G; Gabathuler R
    J Immunol; 1993 Sep; 151(6):2974-85. PubMed ID: 8397249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocytes against the antigen-processing-defective RMA-S tumor cell line.
    Sijts AJ; De Bruijn ML; Nieland JD; Kast WM; Melief CJ
    Eur J Immunol; 1992 Jun; 22(6):1639-42. PubMed ID: 1601045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of beta 2-microglobulin in the intracellular transport and surface expression of murine class I histocompatibility molecules.
    Williams DB; Barber BH; Flavell RA; Allen H
    J Immunol; 1989 Apr; 142(8):2796-806. PubMed ID: 2649560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of peptide binding to purified antibody-bound H-2Db and H-2Db beta 2m complexes.
    Burshtyn DN; Barber BH
    J Immunol; 1993 Sep; 151(6):3082-93. PubMed ID: 7690793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex class I-binding peptides are recycled to the cell surface after internalization.
    Abdel Motal UM; Zhou X; Joki A; Siddiqi AR; Srinivasa BR; Stenvall K; Dahmén J; Jondal M
    Eur J Immunol; 1993 Dec; 23(12):3224-9. PubMed ID: 8258337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular peptide composition governed by major histocompatibility complex class I molecules.
    Falk K; Rötzschke O; Rammensee HG
    Nature; 1990 Nov; 348(6298):248-51. PubMed ID: 2234092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.